Filing Details
- Accession Number:
- 0001127602-19-026232
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-07 16:53:27
- Reporting Period:
- 2019-08-05
- Accepted Time:
- 2019-08-07 16:53:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 859737 | Hologic Inc | HOLX | X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844) | 042902449 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1239351 | P Stephen Macmillan | 250 Campus Drive Marlborough MA 01752 | Chairman, President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-08-05 | 215,996 | $22.29 | 1,781,811 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-08-05 | 112,451 | $48.41 | 1,669,360 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-08-05 | 81,945 | $49.26 | 1,587,415 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2019-08-05 | 215,996 | $0.00 | 215,996 | $22.29 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 647,988 | 2014-12-06 | 2020-12-06 | No | 4 | M | Direct |
Footnotes
- Transaction pursuant to an existing Rule 10b5-1 trading plan, which plan was described in the Form 8-K filed by Hologic on June 4, 2019.
- Includes 1,045,901 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan.
- The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $47.985 to $48.97 per share. The Reporting Person will provide, upon request from Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (3) and (4) to this Form 4.
- The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $48.99 to $49.76 per share. The Reporting Person will provide, upon request by Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (3) and (4) to this Form 4.
Billionaire Hedge Funds
